What is 'Stock And Warrant Off-Balance Sheet R&D - SWORD'

Stock And Warrant Off-Balance Sheet R&D (SWORD) is a form of financing that helps biotechnology firms access research and development funding while reducing risk to the company. Innovation is a key characteristic for biotech firms to remain competitive in the market, and SWORD financing provides young firms an avenue to create and control their own research sponsors.

BREAKING DOWN 'Stock And Warrant Off-Balance Sheet R&D - SWORD'

Stock And Warrant Off-Balance Sheet R&D (SWORD) is a financing option developed to help biotechnology companies access capital for research and development. SWORD financing establishes a separate entity with the purpose of raising research and development funding.

SWORD financing benefits biotech companies, particularly young companies with little capital on hand, by facilitating the development projects they would otherwise be unable to afford, and reducing the risk to current shareholders.  SWORDs allow companies to minimize the effects of R&D spending on the firm's bottom line.

Investors, often institutional investors or wealthy individuals speculating on emerging technologies, typically benefit from the SWORD approach by receiving a portion of the rights to the R&D outcomes. In some cases, investors will also receive warrants on stock in the parent company.
A typical SWORD agreement establishes an entity serving as a middleman between the biotech firm and the R&D investors. The SWORD will own the property rights to the R&D, usually providing a license in perpetuity to the biotech firm to use the technologies as they develop products and projects. The financial obligations of the SWORD remain fully separate from the parent firm, and financing for this separate entity ultimately comes from a public offering. A SWORD owning a successful technology could then effectively be bought back by the parent company by calling on common stock.

SWORD Impact on Biotechnology and Innovation

As we have seen, SWORD financing provides an important layer of financial security to biotechnology companies, which rely on research and development to remain competitive. The biotechnology sector consists of firms engaged in a wide range of industries, including medicine, pharmaceuticals, food and fuel. Rooted in principles of understanding and manipulating the ways living organisms function, biotechnology has been responsible for enormous advances in areas such as disease control, crop yields, pollution control and human lifespan.

As an economic sector, innovation is a crucial aspect for biotech firms to remain competitive in the market. The risks are high, and the margins are slim, especially for young companies. More traditional forms of funding research and development, including venture capital, strategic alliances, equity financing or debt financing present unattractive barriers to small firms looking to retain control of their company and its returns.

RELATED TERMS
  1. Off-Balance Sheet (OBS)

    Off-balance sheet is the classification of an asset or debt that ...
  2. Off-Balance Sheet Financing

    Off-balance sheet financing is a form of financing in which large ...
  3. Research and Development - R&D

    Research and development refers to the work a business conducts ...
  4. Research And Development (R&D) ...

    Any expenses associated with the research and development of ...
  5. Price-To-Innovation-Adjusted Earnings

    Price-to-innovation-adjusted earnings is a variation of the P/E ...
  6. Financing Entity

    A financing entity is the party in a financing arrangement that ...
Related Articles
  1. Trading

    Biotech Stocks Trade Near Major Levels of Support

    With biotech stocks tumbling toward long-term levels of support, we take a closer look at how active traders will trade the bounce.
  2. Insights

    Pharmaceutical Vs. Biotech Investing: Is It Worth The Risk?

    Investopedia explains: Both pharma and biotech stocks are faced with a costly process that, when successful, can produce extremely profitable products. However, the process is unpredictable.
  3. Insights

    And The King of R&D Spending Is

    When it comes to investing in other countries, knowing how much is being spent on research and development, and where it's be spent, is important for any investor.
  4. Insights

    The Biggest Biotech Companies

    These biotech firms want to revolutionize medicine. If successful, they may see high profits, but investing in these companies carries significant risk.
  5. Investing

    Key Financial Ratios to Analyze Biotech Companies (AMGN, GILD)

    Explore the rapidly growing biotechnology industry, and learn some of the key financial ratios investors use to analyze companies in the industry.
  6. Investing

    A Look at Bank of America Ahead of Earnings (BAC)

    Lowered estimates will make the earnings easier to beat and by a higher margin. But it's a double-edged sword.
  7. Trading

    Biotech Breakouts Suggest It Is Time to Buy

    Bullish chart patterns on key biotech names are presenting traders with the best risk/reward setup of 2017.
  8. Investing

    Biotech ETF Investors are Still on the Sidelines

    Biotech ETFs are surging, but investors aren't taking the bait. Not yet, at least.
  9. Investing

    AMD and Nvidia Could Fall On Cryptocurrency Trend

    Advanced Micro and Nvidia have benefited from the cryptocurrency trend, but is trouble lurking ahead?
  10. Personal Finance

    Save Money the Scottish Way

    Take a trip through history to learn from some (in)famously frugal Scots.
RELATED FAQS
  1. What are the benefits of R&D (research and development)?

    Learn about the many benefits of research and development (R&D) efforts for companies in competitive markets, including the ... Read Answer >>
  2. How much of a drug company's spending is allocated to research and development on ...

    Pharmaceutical companies spend, on average, about 17% of revenues on research and development (R&D), one of the biggest spenders ... Read Answer >>
  3. Biotech vs Pharmaceutical company

    Though biotech and pharmaceutical companies share similar business features, there also have differences. Here, we'll distinguish ... Read Answer >>
  4. What country spends the most on research and development?

    Discover which country spends the most on research and development, in both dollar terms and as a percentage of gross domestic ... Read Answer >>
Trading Center